Ketamine

President Donald Trump has been reportedly referring to Elon Musk as a “big-time drug addict” in private conversations. This comes amidst an escalating fallout between the two high-profile figures. What Happened: A recent report by The Washington Post reveals that Trump...

President Donald Trump said that he has no knowledge of Elon Musk engaging in drug use during the 2024 election cycle, brushing off a media report alleging Musk’s drug consumption while on the campaign trail. According to a recent piece by The New York Times, the billionaire entrepreneur...

Elon Musk took to X to criticize a recent New York Times report alleging he frequently used ketamine during the 2024 campaign. What Happened: On Friday, Musk responded to a comment by Pierre Ferragu, who called the New York Times’ piece on Musk “pathetic.” Musk agreed with Ferragu...

Elon Musk, chair of the Trump the Department of Government Efficiency (DOGE) has expressed support for the idea of mandatory drug testing for federal employees, which could assist his broader efforts to slash government spending and reduce the federal workforce. This comes as DOGE advances a mass...

In the high-pressure, constantly evolving world of Silicon Valley, some of the most influential leaders have turned to psychedelics in their search for creativity, personal growth and mental clarity. As Business Insider reported, from Apple's (NASDAQ:APPL) visionary co-founder Steve Jobs to OpenAI...

Numinus Wellness Inc. (OTCQX:NUMIF), a leader in psychedelic-assisted mental health care, has announced a definitive agreement with Stella, an interventional psychiatry practice, to sell its five wellness clinics in Utah for a total of $3.53 million. The transaction, expected to close by November...

As election season dominated every aspect of American life – from relentless TV ads to heated debates on critical issues – many U.S. citizens found themselves grappling with heightened stress and anxiety. As Double Blind reported, in the wake of the election, the demand for psychedelics...

The global psychedelic drugs market is set for rapid expansion, with projections forecasting growth from $4.88 billion in 2023 to $10.2 billion by 2028, according to The Business Research Company. With a compound annual growth rate of 16.1%, this rise is largely driven by increased awareness of...

Drug-related deaths in England and Wales have surged to their highest level since 1993, according to the latest figures from the Office for National Statistics (ONS). An alarming 5,448 fatalities were registered in 2023 alone, marking an 11% increase from the previous year. Cocaine-related deaths...

In the winter of 2023, combat medic Ihor Kholodylo faced a life-altering event on Ukraine’s eastern front. A shell from a Russian tank struck his medical evacuation van, leaving him severely injured. Though Kholodylo survived, the psychological toll was profound. Despite healing from physical...

A recent pilot study from the University of Washington School of Medicine shows a low dosage of ketamine can reduce or help eliminate withdrawal symptoms from fentanyl addiction. Medical journal Addiction Science & Clinical Practice published the results Tuesday. A 16-milligram dose of...

The death of “Friends” actor Matthew Perry has spurred the Drug Enforcement Administration (DEA) into action. The agency is drawing alarming parallels between the rise in ketamine use and the early days of the opioid epidemic. As Double Blind reported, the DEA is now signaling a...

A recent study conducted by researchers from the University of Liège in Belgium and Imperial College London has revealed striking similarities between the altered states of consciousness experienced during near-death events and those induced by psychedelic drugs. Near-death experiences are more...

Editor’s note: This story has been updated with additional details including the indictment of several people accused of supplying and injecting Perry with large amounts of ketamine leading to his death. Matthew Perry's personal assistant, two doctors and two others have been indicted and...

Pharma giant Johnson & Johnson (NYSE:JNJ) announced Monday it had asked the Food and Drug Administration (FDA) to approve its nasal spray as a monotherapy for treatment-resistant depression (TRD) in adults. The New Jersey-based company's Spravato, contains esketamine as an active ingredient,...